Arduini J. Peter's Insider Trades & SAST Disclosures
Arduini J. Peter's most recent trade in GE HealthCare Technologies Inc was a trade of 119,913 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Arduini J. Peter.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 119,913 | 119,913 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 41,931 | 179,228 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.35 per share. | 01 Mar 2025 | 29,818 | 137,297 | - | 87.3 | 2,604,602 | Common Stock, par value $0.01 per share |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.35 per share. | 01 Mar 2025 | 4,507 | 167,115 | - | 87.3 | 393,686 | Common Stock, par value $0.01 per share |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 67,487 | 171,622 | - | 0 | Common Stock, par value $0.01 per share | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 60,937 | - | - | Deferred Share Units | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.30 per share. | 01 Feb 2025 | 3,206 | 104,135 | - | 88.3 | 283,090 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb Co. | Arduini Peter J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 596 | 56,788 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 652 | 55,577 | - | - | Deferred Share Units | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.82 per share. | 01 Sep 2024 | 5,859 | 107,341 | - | 84.8 | 496,960 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 825 | 54,249 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 645 | 52,708 | - | - | Deferred Share Units | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 103,527 | 103,527 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 36,399 | 113,200 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 01 Mar 2024 | 4,444 | 76,801 | - | 91.3 | 405,648 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb Co. | Arduini J. Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 52,063 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | J. Arduini Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 657 | 47,167 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 581 | 45,997 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 527 | 44,999 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 486 | 44,104 | - | - | Deferred Share Units | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 109,994 | 109,994 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 39,425 | 81,245 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 188,127 | 188,127 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 21,425 | 41,820 | - | 0 | Common Stock, par value $0.01 per share | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 2,807 | 43,617 | - | - | Deferred Share Units | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 89,023 | 89,023 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Technologies... | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 20,395 | 20,395 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 469 | 40,485 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 474 | 39,740 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 438 | 38,979 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 462 | 38,266 | - | - | Deferred Share Units | |
| General Electric Co. | Peter J. Arduini | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 63,044 | 63,044 | - | - | Employee Stock Option (right to buy) | |
| General Electric Co. | Peter J. Arduini | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 14,443 | 14,443 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 3,067 | 37,803 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 521 | 34,450 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 549 | 33,648 | - | - | Deferred Share Units | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 75.97 per share. | 02 Sep 2021 | 71,829 | 216,713 (0%) | 0% | 76.0 | 5,456,662 | Common Stock |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.88 per share. | 02 Sep 2021 | 71,829 | 288,542 (0%) | 0% | 20.9 | 1,499,790 | Common Stock |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 71,829 | 46,605 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.88 per share. | 02 Sep 2021 | 46,605 | 263,318 (0%) | 0% | 20.9 | 973,112 | Common Stock |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 46,605 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 75.75 per share. | 02 Sep 2021 | 46,605 | 216,713 (0%) | 0% | 75.8 | 3,530,459 | Common Stock |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 507 | 32,862 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 574 | 32,111 | - | - | Deferred Share Units | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 66,402 | 66,402 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 22,027 | 553,614 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 368 | 216,713 (0%) | 0% | 68.1 | 25,061 | Common Stock |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 368 | 217,081 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 368 | 552,716 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 272 | 216,713 (0%) | 0% | 68.1 | 18,523 | Common Stock |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 272 | 216,985 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 272 | 553,084 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 258 | 216,713 (0%) | 0% | 68.1 | 17,570 | Common Stock |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 258 | 216,971 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 258 | 553,356 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.79 per share. | 01 Feb 2021 | 22,786 | 239,499 (0%) | 0% | 15.8 | 359,791 | Common Stock |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 22,786 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 66.16 per share. | 01 Feb 2021 | 22,786 | 216,713 (0%) | 0% | 66.2 | 1,507,442 | Common Stock |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,054 | 31,537 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 584 | 28,260 | - | - | Deferred Share Units | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2020 | 45,000 | 22,786 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.79 per share. | 18 Dec 2020 | 45,000 | 261,713 (0%) | 0% | 15.8 | 710,550 | Common Stock |
| Integra Lifesciences Holdi... | Peter J. Arduini | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 61.97 per share. | 18 Dec 2020 | 45,000 | 216,713 (0%) | 0% | 62.0 | 2,788,781 | Common Stock |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 601 | 27,468 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 616 | 26,664 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb Co. | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2020 | 650 | 25,854 | - | - | Deferred Share Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges